Follicular Lymphoma Foundation update

I just read an update from the Follicular Lymphoma Foundation with news of a collaboration with the University of Pennsylvania's School of Clinical Medicine. This programme to include trialling an approved bispecific as a first-line treatment for follicular and a revolutionary new CAR-T as a second line. This sort of work is incredibly exciting to hear about. Chemotherapy is crude by comparison with treatments that result in the immune system itself dealing with the cancer. Surely this one day will be the way FL is cured.